Macroview Investment Management’s AdvisorShares Alpha DNA Equity Sentiment ETF SENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-121
Closed -$2.73K 523
2022
Q4
$2.73K Sell
121
-19
-14% -$436 ﹤0.01% 355
2022
Q3
$3K Sell
140
-5,163
-97% -$114K 0.01% 331
2022
Q2
$110K Sell
5,303
-70,475
-93% -$1.57M 0.18% 67
2022
Q1
$1.81M Buy
75,778
+12,374
+20% +$305K 2.59% 12
2021
Q4
$1.75M Buy
63,404
+8,523
+16% +$235K 2.24% 17
2021
Q3
$1.47M Buy
+54,881
New +$1.5M 1.9% 19

Other funds holding SENT

Macroview Investment Management's SENT Position: Q1 2023 in Review

Macroview Investment Management sold out of AdvisorShares Alpha DNA Equity Sentiment ETF (SENT) in Q1 2023, closing a stake of 121 shares — an estimated $2.73K sold.

Macroview Investment Management first reported a position in SENT in Q3 2021 and held it in 6 quarters. The position peaked at $1.81M in Q1 2022. 9 funds tracked by Wall St. Rank hold SENT as of Q1 2023.

  • Macroview Investment Management reported no remaining AdvisorShares Alpha DNA Equity Sentiment ETF position as of Q1 2023 after selling out during the quarter.
  • Macroview Investment Management sold 121 AdvisorShares Alpha DNA Equity Sentiment ETF shares in Q1 2023, an estimated $2.73K.
  • Macroview Investment Management first reported a position in AdvisorShares Alpha DNA Equity Sentiment ETF in Q3 2021 and held it in 6 quarters.
  • Macroview Investment Management's AdvisorShares Alpha DNA Equity Sentiment ETF position peaked at $1.81M in Q1 2022.
  • 9 funds tracked by Wall St. Rank held AdvisorShares Alpha DNA Equity Sentiment ETF as of Q1 2023.

Based on Macroview Investment Management's 13F filing for Q1 2023, filed 18 Apr 2023.